Codexis (CDXS) to Release Quarterly Earnings on Wednesday

Codexis (NASDAQ:CDXS) is expected to be announcing its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $27.41 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Codexis Stock Up 2.0 %

Shares of NASDAQ:CDXS opened at $4.40 on Wednesday. The company has a current ratio of 3.21, a quick ratio of 3.15 and a debt-to-equity ratio of 0.39. Codexis has a 12 month low of $2.56 and a 12 month high of $6.08. The company has a 50-day moving average price of $4.80 and a 200 day moving average price of $3.91. The company has a market cap of $357.67 million, a price-to-earnings ratio of -5.05 and a beta of 2.12.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on CDXS shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $11.00 price target on shares of Codexis in a report on Friday, November 22nd. Benchmark reaffirmed a “hold” rating on shares of Codexis in a report on Monday, November 4th.

Codexis Company Profile

Codexis, Inc discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.